Compound Evidence File
#EC-2026-0682
Semax
Filed under Peptides. The bureau holds 174 laboratory returns for this compound from 77 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
77 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 10.0 | 9.9 | 10.0 | 3 Mar 2026 | 28 Jun 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 4 | 10.0 | 10.0 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 9.9 | 10.0 | 28 Apr 2026 | 2 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 10.0 | 9.9 | 10.0 | 9 Nov 2025 | 10 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 10.0 | 9.9 | 10.0 | 19 Dec 2025 | 15 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 9.9 | 10.0 | 18 Mar 2026 | 16 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 10.0 | 9.9 | 10.0 | 27 Jan 2026 | 3 Aug 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 10.0 | 9.9 | 10.0 | 10 Apr 2026 | 14 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 10.0 | 9.9 | 10.0 | 17 Feb 2026 | 18 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 9.9 | 10.0 | 15 Apr 2026 | 11 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 10.0 | 10.0 | 10.0 | 3 May 2026 | 22 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 10.0 | 10.0 | 10.0 | 12 Jun 2026 | 17 Jun 2026 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 10.0 | 10.0 | 10.0 | 28 Mar 2025 | 28 Mar 2025 |
| Xianhong Tong XHT PeptidesCASE #VI-2026-0997 | X | 1 | 10.0 | 10.0 | 10.0 | 2 Apr 2025 | 2 Apr 2025 |
| Tianjin Ruiwang New Material Technology CoCASE #VI-2026-0192 | X | 1 | 10.0 | 10.0 | 10.0 | 2 Apr 2025 | 2 Apr 2025 |
| Peptide CraftersCASE #VI-2026-0994 | X | 1 | 10.0 | 10.0 | 10.0 | 14 Jan 2025 | 14 Jan 2025 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 9.9 | 9.9 | 10.0 | 28 Apr 2026 | 11 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 9.9 | 9.9 | 10.0 | 5 Dec 2025 | 3 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 9.9 | 9.9 | 10.0 | 18 Jan 2026 | 25 Jun 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 9.9 | 9.9 | 10.0 | 27 Mar 2026 | 1 Aug 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 16 Mar 2026 | 18 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 10.0 | 4 Nov 2025 | 20 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 9.9 | 9.9 | 9.9 | 22 Apr 2026 | 9 May 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 9.9 | 9.9 | 10.0 | 26 May 2026 | 13 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 9.9 | 9.9 | 10.0 | 24 Apr 2026 | 21 Jul 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 9.9 | 17 Apr 2026 | 6 May 2026 |
| TCICASE #VI-2026-0650 | X | 1 | 9.8 | 9.8 | 9.8 | 14 Jan 2025 | 14 Jan 2025 |
| Shanghai Wibson Biotechnology WBSCASE #VI-2026-0214 | X | 1 | 9.5 | 9.5 | 9.5 | 13 Jun 2025 | 13 Jun 2025 |
| Aavant ResearchCASE #VI-2026-0831 | X | 1 | 9.5 | 9.5 | 9.5 | 17 Dec 2024 | 17 Dec 2024 |
| CellupepCASE #VI-2026-0888 | X | 1 | 9.2 | 9.2 | 9.2 | 3 Jul 2025 | 3 Jul 2025 |
| Welon Peptide SolutionsCASE #VI-2026-0478 | X | 1 | 8.9 | 8.9 | 8.9 | 3 Jul 2025 | 3 Jul 2025 |
| Bfflist AMOCASE #VI-2026-0678 | X | 6 | 8.8 | 6.9 | 9.9 | 11 Jun 2025 | 20 May 2026 |
| BeiBangAnCASE #VI-2026-0899 | X | 2 | 8.6 | 8.3 | 8.8 | 14 Jan 2025 | 26 Jan 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 6 | 8.4 | 7.2 | 10.0 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 6 | 8.3 | 6.9 | 9.3 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 2 | 8.3 | 8.0 | 8.7 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 8.2 | 6.9 | 9.0 | 24 May 2026 | 24 May 2026 |
| Verified PeptidesCASE #VI-2026-0407 | X | 2 | 8.2 | 8.1 | 8.3 | 13 Feb 2025 | 19 Jan 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 2 | 8.0 | 7.6 | 8.4 | 24 May 2026 | 24 May 2026 |
| Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 | X | 1 | 7.8 | 7.8 | 7.8 | 3 Jul 2025 | 3 Jul 2025 |
| Peptide-SCASE #VI-2026-0111 | X | 7 | 7.6 | 5.8 | 9.5 | 3 Jul 2025 | 24 May 2026 |
| Diju Peptides Wellness and CoCASE #VI-2026-0724 | X | 1 | 7.4 | 7.4 | 7.4 | 16 Mar 2025 | 16 Mar 2025 |
| Peptide HavenCASE #VI-2026-0898 | X | 1 | 7.4 | 7.4 | 7.4 | 27 Feb 2025 | 27 Feb 2025 |
| Henan Sahe PeptideCASE #VI-2026-0894 | X | 1 | 7.3 | 7.3 | 7.3 | 11 Jun 2025 | 11 Jun 2025 |
| Simple PeptideCASE #VI-2026-0782 | X | 1 | 7.2 | 7.2 | 7.2 | 2 Apr 2025 | 2 Apr 2025 |
| BfflinkCASE #VI-2026-0212 | X | 1 | 7.2 | 7.2 | 7.2 | 25 Apr 2025 | 25 Apr 2025 |
| Royal PeptidesCASE #VI-2026-0264 | X | 3 | 7.1 | 6.5 | 8.0 | 9 Jun 2025 | 17 May 2026 |
| Hangzhou Youngpeptide Biotechnology HYBCASE #VI-2026-0347 | X | 1 | 7.1 | 7.1 | 7.1 | 8 Jul 2025 | 8 Jul 2025 |
| EHZ PeptidesCASE #VI-2026-0296 | C | 2 | 7.0 | 6.0 | 8.0 | 9 Jun 2025 | 21 May 2026 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | X | 1 | 6.7 | 6.7 | 6.7 | 17 Dec 2024 | 17 Dec 2024 |
| ZLZ PeptideCASE #VI-2026-0524 | X | 7 | 6.5 | 3.7 | 8.6 | 25 Apr 2025 | 21 May 2026 |
| PurePEPSCASE #VI-2026-0552 | X | 1 | 6.4 | 6.4 | 6.4 | 24 Apr 2025 | 24 Apr 2025 |
| Heman Peptide HMCASE #VI-2026-0089 | X | 2 | 6.3 | 4.0 | 8.6 | 16 Mar 2025 | 23 May 2026 |
| Hunan Ruiwang Technology CenterCASE #VI-2026-0027 | X | 1 | 6.2 | 6.2 | 6.2 | 24 Apr 2025 | 24 Apr 2025 |
| Evolve BioPepCASE #VI-2026-0755 | X | 1 | 6.2 | 6.2 | 6.2 | 14 Jan 2025 | 14 Jan 2025 |
| Loti LabsCASE #VI-2026-0171 | X | 3 | 6.1 | 3.6 | 7.7 | 3 Jul 2025 | 17 May 2026 |
| LSPLCASE #VI-2026-0523 | X | 4 | 5.8 | 4.4 | 6.7 | 17 Dec 2024 | 17 May 2026 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | X | 2 | 5.8 | 5.1 | 6.4 | 6 May 2025 | 21 May 2026 |
| Golden EagleCASE #VI-2026-0680 | X | 1 | 5.8 | 5.8 | 5.8 | 2 Jul 2025 | 2 Jul 2025 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | X | 2 | 5.7 | 5.6 | 5.8 | 3 Jul 2025 | 17 May 2026 |
| Kerisite Shenzhen InternationalCASE #VI-2026-0315 | X | 1 | 5.7 | 5.7 | 5.7 | 9 Jun 2025 | 9 Jun 2025 |
| Modern AminosCASE #VI-2026-0635 | X | 1 | 5.6 | 5.6 | 5.6 | 2 Apr 2025 | 2 Apr 2025 |
| Haikou Mingheng BiotechnologyCASE #VI-2026-0126 | X | 1 | 5.5 | 5.5 | 5.5 | 2 Apr 2025 | 2 Apr 2025 |
| Dragon PharmaCASE #VI-2026-0519 | X | 1 | 5.4 | 5.4 | 5.4 | 25 Apr 2025 | 25 Apr 2025 |
| DeuschemCASE #VI-2026-0004 | X | 1 | 5.4 | 5.4 | 5.4 | 20 Jun 2025 | 20 Jun 2025 |
| Platinum CryoCASE #VI-2026-0406 | X | 1 | 5.2 | 5.2 | 5.2 | 24 Apr 2025 | 24 Apr 2025 |
| ZZQ PeptidesCASE #VI-2026-0550 | X | 1 | 5.1 | 5.1 | 5.1 | 7 May 2025 | 7 May 2025 |
| Regenerative ResearchCASE #VI-2026-0349 | X | 1 | 5.1 | 5.1 | 5.1 | 2 Jul 2025 | 2 Jul 2025 |
| Forever Young PharmacyCASE #VI-2026-0654 | X | 1 | 5.0 | 5.0 | 5.0 | 11 Jun 2025 | 11 Jun 2025 |
| Mix PeptidesCASE #VI-2026-0699 | X | 2 | 4.8 | 3.9 | 5.7 | 3 Jul 2025 | 24 May 2026 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | X | 1 | 4.5 | 4.5 | 4.5 | 28 Mar 2025 | 28 Mar 2025 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 3.3 | 3.3 | 3.3 | 25 Apr 2025 | 25 Apr 2025 |
| Amplified AminoCASE #VI-2026-0748 | X | 1 | 3.0 | 3.0 | 3.0 | 13 Feb 2025 | 13 Feb 2025 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 0.0 | 0.0 | 0.0 | 3 Jun 2025 | 3 Jun 2025 |
| Advanced Technology and IndustrialCASE #VI-2026-0133 | X | 1 | 0.0 | 0.0 | 0.0 | 3 Jun 2025 | 3 Jun 2025 |
| Qingdao VitaConin International TradingCASE #VI-2026-0504 | X | 1 | 0.0 | 0.0 | 0.0 | 20 Jun 2025 | 20 Jun 2025 |
Open any subject to view the batch-level evidence for Semax alone.